272 related articles for article (PubMed ID: 25501571)
1. Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data.
Tomino Y
Kidney Blood Press Res; 2014; 39(5):450-89. PubMed ID: 25501571
[TBL] [Abstract][Full Text] [Related]
2. IgA nephropathy: lessons from an animal model, the ddY mouse.
Tomino Y
J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of patients with IgA nephropathy in Japan.
Tomino Y
Kidney Res Clin Pract; 2016 Dec; 35(4):197-203. PubMed ID: 27957413
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathy.
Tomino Y
Nephrology (Carlton); 2010 Feb; 15(1):1-6. PubMed ID: 20377762
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histological features and therapeutic strategies for IgA nephropathy.
Moriyama T
Clin Exp Nephrol; 2019 Sep; 23(9):1089-1099. PubMed ID: 30968243
[TBL] [Abstract][Full Text] [Related]
7. How to treat patients with chronic kidney disease: With special focus on IgA nephropathy.
Tomino Y
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():76-79. PubMed ID: 30298660
[TBL] [Abstract][Full Text] [Related]
8. Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.
Tomino Y
Clin Exp Nephrol; 2011 Feb; 15(1):1-7. PubMed ID: 21057848
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A nephropathy and chronic kidney disease.
Tomino Y
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():23-6. PubMed ID: 20586943
[TBL] [Abstract][Full Text] [Related]
10. IgA nephropathy. From molecules to men.
Tomino Y
Contrib Nephrol; 1999; 126():III-IX, 1-115. PubMed ID: 10489630
[TBL] [Abstract][Full Text] [Related]
11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
12. The Prevalence and Management of Diabetic Nephropathy in Asia.
Tomino Y; Gohda T
Kidney Dis (Basel); 2015 May; 1(1):52-60. PubMed ID: 27536665
[TBL] [Abstract][Full Text] [Related]
13. Predictors of prognosis in IgA nephropathy.
Tomino Y
Kaohsiung J Med Sci; 2012 Oct; 28(10):517-20. PubMed ID: 23089315
[TBL] [Abstract][Full Text] [Related]
14. Defining the spectrum of immunoglobulin A-dominant/codominant glomerular deposition in diabetic nephropathy.
Cossey LN; Messias N; Messias E; Walker PD; Silva FG
Hum Pathol; 2014 Nov; 45(11):2294-301. PubMed ID: 25239033
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of patients with IgA nephropathy and long-term survival after dialysis therapy].
Komatsu H; Nakagawa H; Iwakiri T; Toida T; Fukuda A; Kikuchi M; Sato Y; Kitamura K; Fujimoto S
Nihon Jinzo Gakkai Shi; 2014; 56(8):1251-9. PubMed ID: 25551986
[TBL] [Abstract][Full Text] [Related]
16. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
[TBL] [Abstract][Full Text] [Related]
17. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
[TBL] [Abstract][Full Text] [Related]
18. Hematuria and risk for end-stage kidney disease.
Vivante A; Calderon-Margalit R; Skorecki K
Curr Opin Nephrol Hypertens; 2013 May; 22(3):325-30. PubMed ID: 23449218
[TBL] [Abstract][Full Text] [Related]
19. Primary glomerulonephritides.
Floege J; Amann K
Lancet; 2016 May; 387(10032):2036-48. PubMed ID: 26921911
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
Floege J
Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
